Loading company…
MedTrace Pharma develops medical technology for producing and using 15O-water in perfusion imaging.
Founded in 2015 and based in Horsholm, MedTrace Pharma develops medical devices, software, and drugs for patient diagnosis. Its P3 automated chemistry system produces and infuses 15O-water for perfusion imaging, while its software quantifies myocardial blood flow using PET scanners. In September 2023, the company raised EUR 18.2 million from ATP, MedTravest, Swisscanto, and Verve Ventures to support a phase 3 trial, software development, and regulatory approvals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in